Evidence map›Paper›PMID 41614769›Full record

ArticleCurrent issues in molecular biology2025

In Silico and Wet Analysis of

Marta Żebrowska-Nawrocka, Rafał Świechowski, Dagmara Szmajda-Krygier, Bartosz Lenda, Marek Mirowski, Michał Czaplij, Mariusz Balcerczak, Ewa Balcerczak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta Żebrowska-NawrockaDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0001-7478-7860
Rafał ŚwiechowskiDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0003-2923-273X
Dagmara Szmajda-KrygierDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0002-9524-6032
Bartosz LendaDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0003-1035-5908
Marek MirowskiDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0001-9243-0275
Michał CzaplijDepartment of Surgery, District Hospital in Leczyca,99-100 Leczyca, Poland.
Mariusz BalcerczakDepartment of Surgery, District Hospital in Leczyca,99-100 Leczyca, Poland.
Ewa BalcerczakDepartment of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0001-5257-2914

Funding

Medical University of Lodz 503/3-015-02/503-31-001
6 · The paper itself

Abstract

Peptic ulcer disease and gastric cancer are influenced by both environmental factors and genetic background. One such genetic factor is changes in the

Indexed as

apoptosisBAXcarcinogenesisexpressionpolymorphismsrs4645878SNP G-248A

Identifiers

PMID41614769
PMCPMC12731365

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.